BCTX 2.83 + 10% low float ..the Company will be presenting three posters at the 2024 American Association for Cancer Research (AACR) Annual Meeting taking place April 5-10 at San Diego Convention Center, San Diego, CA. The details are listed below.
Poster 1: Title: Efficacy of Bria-IMT regimen in inducing CNS metastasis regression Session Title: Phase II Clinical Trials 1 Session Date and Time: Tuesday Apr 9, 2024, 9:00 AM - 12:30 PM PST Location: Poster Section 49 Poster Board Number: 4 Abstract Presentation Number: CT204
Poster 2: Title: Efficacy and safety of SV-BR-1-GM after progression on ADC in metastatic breast cancer patients Session Title: Phase II Clinical Trials 1 Session Date and Time: Tuesday Apr 9, 2024, 9:00 AM - 12:30 PM PST Location: Poster Section 49 Poster Board Number: 6 Abstract Presentation Number: CT206
Poster 3: Title: Bria-OTS immunotherapy platform: Harnessing gene-modified tumor cells to reinvigorate the cancer immunity cycle for precision anti-tumor responses Session Category: Immunology Session Title: Vaccines, Antigens, and Antigen Presentation 2 Session Date and Time: Wednesday Apr 10, 2024, 9:00 AM - 12:30 PM PST Location: Poster Section 4 Poster Board Number: 22 Abstract Presentation Number: 6753
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.